Genexine to Raise KRW 3 Billion in Share Offering
Genexine will issue 1,250,500 common shares through a third-party allotment to raise KRW 3 billion for working capital. Korea Quantum AI will purchase the shares at KRW 2,399 each, a 10% discount to the reference price. Subscription is scheduled for October 20, 2026, with payment due October 26, 2026. The new shares ar